About Milu Labs
Milu Labs is a Healthcare company based in New York (United States) founded in 2018. Exosome-based diagnostic products for health screening are offered. Milu Labs offers products and services including Preterm Birth Test, Exosomes Platform, and Multiomics Approach. Its focus areas include Life Sciences, Women Health, In Vitro Diagnostic Tests and Fertility. Its competitors include Natera, Cepheid and Beckman Coulter; 2 of its 3 listed competitors have raised funding.
Company details
Milu Labs was founded in 2018 and is headquartered in New York, United States. Diagnostic products based on exosomes and other platforms are developed by the company for screening and detecting major health conditions. Operations are centered on maternal-fetal medicine and womens health sectors. Systems and tools are provided to support these areas within the biotechnology industry.
- Headquarters New York, United States
- SectorsHealthcare
- Email••••••••
- Website milulabs.com
- InvestorsMAGNA Investment
& 1 more
Products & Services of Milu Labs
Milu Labs offers a comprehensive portfolio of products and services, including Preterm Birth Test, Exosomes Platform, and Multiomics Approach.
Noninvasive diagnostic for predicting preterm birth risk early in pregnancy.
Utilizes exosomes for bio-fingerprinting to predict future health risks.
Combines proteome and epigenome analysis for comprehensive clinical insights.
Funding Insights of Milu Labs
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Milu Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | Seed | – | MAGNA Investment |
2 investors in total: 2 institutional.
Investors in Milu Labs
Milu Labs has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include MAGNA Investment and Turret Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A multi-asset investment firm based in Abu Dhabi, UAE, is operated. | 2005 | magna.ae | Abu Dhabi, United Arab Emirates | |
Turret Capital is engaged in early stage healthcare investments. | turretfunds.com | New York, United States |
Investor details for Milu Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Milu Labs
8 people are tracked at Milu Labs (2 in leadership, 5 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Ludy Bao | Head of Business Development | Leadership |
Ziyun Zhang | Director of Corporate Affairs | Leadership |
Daniel Chai | Co-Founder & Chairman | Board & advisors |
Thomas McElrath | Scientific Advisor | Board & advisors |
Daniel W. Chan | Scientific Advisor | Board & advisors |
Gail S. Page | Scientific Advisor | Board & advisors |
Zhen Zhang | Scientific Advisor | Board & advisors |
Haohuan Li | Industry Research Analyst | Team |
Complete people profiles for Milu Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Milu Labs
2 dated milestones of Milu Labs across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Milu Labs is founded.
- Funding First funding round.
Competitors of Milu Labs
Milu Labs has 3 listed competitors in our database, 2 of them funded. They include Natera, Cepheid and Beckman Coulter.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| beckman.com | 1935 | Brea, United States | Provider of products for biomedical testing for R&D, diagnostic and commercial applications |
Detailed competitors of Milu Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Milu Labs (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Milu Labs
Complete news archive for Milu Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Milu Labs
Milu Labs was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Milu Labs is headquartered in New York, United States. It is registered at New York, New York, United States.
Milu Labs was founded in 2018 and is headquartered in New York, United States. Diagnostic products based on exosomes and other platforms are developed by the company for screening and detecting major health conditions. Operations are centered on maternal-fetal medicine and womens health sectors. Systems and tools are provided to support these areas within the biotechnology industry.
Milu Labs's top competitors include Cepheid, Natera and Beckman Coulter.
Milu Labs offers Preterm Birth Test, Exosomes Platform, and Multiomics Approach.
Milu Labs has 2 investors. Key investors include MAGNA Investment, and Turret Capital.